HTA32 When Should the Conduct of RWE Studies Be Prioritized for Reimbursement: Insights from Canadian and Global Stakeholders
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.1717
https://www.valueinhealthjournal.com/article/S1098-3015(23)04847-7/fulltext
Title :
HTA32 When Should the Conduct of RWE Studies Be Prioritized for Reimbursement: Insights from Canadian and Global Stakeholders
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04847-7&doi=10.1016/j.jval.2023.09.1717
First page :
Section Title :
Open access? :
No
Section Order :
11164